Posted inBusiness Insights
Novartis Shares Drop Following Del-Desiran Drug Trial Disappointment
Novartis experiences a significant share price decline after disappointing results from the del-desiran clinical trial and recent setbacks.
Posted inEmerging Market
European Markets Steady as Rising Oil Prices Fuel Inflation Worries and ECB Rate Speculation
European shares remained subdued as surging crude oil prices and rising geopolitical tensions sparked renewed inflation concerns and ECB rate hike speculation.
